Michael V. Airola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael V. Airola has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
Shujuan Gao
Stony Brook University
10 shared publications- Yusuf A. Hannun
Stony Brook University
9 shared publications - John E. Burke
Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, V8W 2Y2, Canada
8 shared publications - Brian R. Crane
Department of Chemistry and Chemical Biology, Cornell University
6 shared publications Reece M. Hoffmann
Department of Biochemistry and Microbiology, University of Victoria, Victoria, Canada
6 shared publications- Daniel Canals
Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook NY 11794
5 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (16) , 2548-2556
Development of a FRET-Based Assay for Human Neutral Sphingomyelinase 2
Neutral sphingomyelinase 2 (nSMase2) is a membrane-bound enzyme that hydrolyzes sphingomyelin (SM) into ceramide and phosphocholine. By generating the bioactive lipid ceramide, nSMase2 plays a critical role in cell stress responses and in regulating exosomes that package and transfer pathogenic factors, including tau protein and amyloid β. Thus, nSMase2 has been implicated in Alzheimer’s disease and other neurological disorders. However, current tools to measure nSMase2 activity are limited, in particular those that could be used in therapeutic development. Here we developed a high-throughput assay to measure human nSMase2 activity. The assay uses a sphingomyelin substrate analogue with a FRET donor and acceptor pair attached to the headgroup and acyl-chain, respectively. Using recombinant human nSMase2, we sensitively detected both wild-type and mutant activity and demonstrated inhibition by the known nSMase2 inhibitor GW4869. The assay captures the major hallmarks of nSMase2 regulation by anionic lipids and displays sensitivity capable of detecting nSMase2 activity from cell lysates. Together, this assay enables rapid screening of nSMase2 inhibitors to support future therapeutic development.
- 7 August 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (16) , 2548-2556
Open AccessDevelopment of a FRET-Based Assay for Human Neutral Sphingomyelinase 2
Neutral sphingomyelinase 2 (nSMase2) is a membrane-bound enzyme that hydrolyzes sphingomyelin (SM) into ceramide and phosphocholine. By generating the bioactive lipid ceramide, nSMase2 plays a critical role in cell stress responses and in regulating exosomes that package and transfer pathogenic factors, including tau protein and amyloid β. Thus, nSMase2 has been implicated in Alzheimer’s disease and other neurological disorders. However, current tools to measure nSMase2 activity are limited, in particular those that could be used in therapeutic development. Here we developed a high-throughput assay to measure human nSMase2 activity. The assay uses a sphingomyelin substrate analogue with a FRET donor and acceptor pair attached to the headgroup and acyl-chain, respectively. Using recombinant human nSMase2, we sensitively detected both wild-type and mutant activity and demonstrated inhibition by the known nSMase2 inhibitor GW4869. The assay captures the major hallmarks of nSMase2 regulation by anionic lipids and displays sensitivity capable of detecting nSMase2 activity from cell lysates. Together, this assay enables rapid screening of nSMase2 inhibitors to support future therapeutic development.
- Open Access
- 28 July 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (9) , 113375
Structural insights into the activation of phospholipase D1 by the small GTPase ARL11
- 28 July 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (9) , 113375
Open AccessStructural insights into the activation of phospholipase D1 by the small GTPase ARL11
- Open Access
- 17 July 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (8) , 101105
Dithionite quenching of NBD-labeled lipids reveals artificial lipid droplet purity and neutral lipid surface accessibility
- 17 July 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (8) , 101105
Open AccessDithionite quenching of NBD-labeled lipids reveals artificial lipid droplet purity and neutral lipid surface accessibility
- Open Access
Dithionite quenching of NBD-labeled lipids reveals artificial lipid droplet purity and neutral lipid surface accessibility
Artificial lipid droplets (aLDs) provide a controllable platform for studying lipid biochemistry, but their use is limited by contamination with other membrane structures and the lack of quantitative methods to assess sample purity. Here, we establish dithionite quenching of NBD-labeled lipids as a simple approach to evaluate aLD purity. The approach relies on dithionite’s ability to selectively quench NBD fluorophores exposed in the phospholipid monolayer of aLDs and in the outer leaflet of liposome bilayers, but not those protected within the inner leaflet of liposome bilayers. Consistent with liposome contamination, bulk aLD preparations exhibit incomplete quenching, which can be separated by sucrose gradient centrifugation into liposome-like and droplet-enriched populations based on quenching behavior. Guided by this assay, sonication conditions were optimized to increase aLD purity and reduce liposome contamination. A biotin–streptavidin immobilization strategy further enabled stable imaging of individual aLDs. Finally, we applied dithionite quenching to probe the accessibility of neutral lipids within aLDs. This revealed hydrophobicity-dependent quenching kinetics of neutral lipids, with less hydrophobic diacylglycerols showing greater surface exposure within aLDs than more hydrophobic triacylglycerols and cholesterol esters. Taken together, these establish dithionite quenching of NBD-labeled lipids as a simple quantitative method for assessing aLD purity and demonstrate its utility for studying lipid accessibility.
Open AccessDithionite quenching of NBD-labeled lipids reveals artificial lipid droplet purity and neutral lipid surface accessibility
Artificial lipid droplets (aLDs) provide a controllable platform for studying lipid biochemistry, but their use is limited by contamination with other membrane structures and the lack of quantitative methods to assess sample purity. Here, we establish dithionite quenching of NBD-labeled lipids as a simple approach to evaluate aLD purity. The approach relies on dithionite’s ability to selectively quench NBD fluorophores exposed in the phospholipid monolayer of aLDs and in the outer leaflet of liposome bilayers, but not those protected within the inner leaflet of liposome bilayers. Consistent with liposome contamination, bulk aLD preparations exhibit incomplete quenching, which can be separated by sucrose gradient centrifugation into liposome-like and droplet-enriched populations based on quenching behavior. Guided by this assay, sonication conditions were optimized to increase aLD purity and reduce liposome contamination. A biotin–streptavidin immobilization strategy further enabled stable imaging of individual aLDs. Finally, we applied dithionite quenching to probe the accessibility of neutral lipids within aLDs. This revealed hydrophobicity-dependent quenching kinetics of neutral lipids, with less hydrophobic diacylglycerols showing greater surface exposure within aLDs than more hydrophobic triacylglycerols and cholesterol esters. Taken together, these establish dithionite quenching of NBD-labeled lipids as a simple quantitative method for assessing aLD purity and demonstrate its utility for studying lipid accessibility.
- Open Access
Nir1-Nir2 Heterodimerization Confers Robustness to the Phosphoinositide Cycle
The phosphatidylinositol (PI) cycle maintains plasma membrane (PM) phosphatidylinositol 4,5-bisphosphate (PIP2) levels to sustain signaling and cellular homeostasis in receptor-stimulated cells. This process requires recruitment of the PI transfer protein Nir2 to endoplasmic reticulum (ER)-PM junctions where PI and phosphatidic acid are exchanged between the two membranes. Nir2 recruitment is promoted by its paralog Nir1, which lacks PI transfer activity but is constitutively localized to ER-PM junctions; however, the mechanism underlying this regulation has remained unclear. Here, we identify and determine crystal structures of a conserved Nir Dimerization (NirD) domain in Nir1 and Nir2. Mutations that disrupt NirD domain dimerization abolish Nir1-mediated recruitment of Nir2 and impair PIP2 replenishment driven by Nir1-Nir2 dimerization in receptor-stimulated cells. Mechanistically, Nir1-Nir2 dimerization enables graded recruitment of Nir2 in proportion to stimulus strength, thereby expanding both the sensitivity and dynamic range of PI cycle responses. Together, this defines the structural basis of Nir1-dependent Nir2 recruitment and reveals a mechanism that confers robustness to the PI cycle, enabling precise homeostatic signaling across a wide range of stimulus intensities.
Open AccessNir1-Nir2 Heterodimerization Confers Robustness to the Phosphoinositide Cycle
The phosphatidylinositol (PI) cycle maintains plasma membrane (PM) phosphatidylinositol 4,5-bisphosphate (PIP2) levels to sustain signaling and cellular homeostasis in receptor-stimulated cells. This process requires recruitment of the PI transfer protein Nir2 to endoplasmic reticulum (ER)-PM junctions where PI and phosphatidic acid are exchanged between the two membranes. Nir2 recruitment is promoted by its paralog Nir1, which lacks PI transfer activity but is constitutively localized to ER-PM junctions; however, the mechanism underlying this regulation has remained unclear. Here, we identify and determine crystal structures of a conserved Nir Dimerization (NirD) domain in Nir1 and Nir2. Mutations that disrupt NirD domain dimerization abolish Nir1-mediated recruitment of Nir2 and impair PIP2 replenishment driven by Nir1-Nir2 dimerization in receptor-stimulated cells. Mechanistically, Nir1-Nir2 dimerization enables graded recruitment of Nir2 in proportion to stimulus strength, thereby expanding both the sensitivity and dynamic range of PI cycle responses. Together, this defines the structural basis of Nir1-dependent Nir2 recruitment and reveals a mechanism that confers robustness to the PI cycle, enabling precise homeostatic signaling across a wide range of stimulus intensities.
- Open Access
Van der Waals interactions mediate the enantiomeric substrate preference of the CTP:phosphoglycerate cytidylyltransferase CpgD
Caulobacter crescentus is a gram-negative bacterium that produces the anionic sphingolipid ceramide diphosphoglycerate that can substitute for the lipopolysaccharide component of the outer membrane. ccna_01210 is a gene in the operon for ceramide diphosphoglycerate synthesis and encodes for the enzyme, CpgD. CpgD is a magnesium-dependent CTP:phosphoglycerate cytidylyltransferase that catalyzes the synthesis of CDP-glycerate, and a pyrophosphate byproduct. CpgD displays substrate specificity for the nucleotide CTP and a preference for 2-phospho-D-glycerate over other phosphoglycerate enantiomers and isomers. Here, we present five high resolution structures for CpgD in various catalytic states that rationalize the specificity and preference of CpgD for its two substrates. This includes structures of apo CpgD, a CpgD-CTP-Mg 2+ ternary complex, and three CpgD-CDP-glycerate-pyrophosphate-Mg 2+ product bound complexes. The structures reveal CpgD nucleotide specificity is mediated by favorable hydrogen bonding interactions with the cytosine nucleobase of CTP, while the preference for 2-phospho-D-glycerate occurs due to favorable van der Waals interactions with the 2D enantiomer and unfavorable steric clashes with the 2L enantiomer. A catalytic mechanism involving a pentacoordinate transition state is proposed based on the observed stereochemical inversion of the α-phosphate in the substrate CTP in comparison to the α-phosphate of the product CDP-glycerate. Overall, this provides insights into the catalytic mechanism, nucleotide specificity, and enantiomeric substrate preference of the cytidylyltransferase CpgD that participates in a unique pathway of bacterial sphingolipid synthesis.
Open AccessVan der Waals interactions mediate the enantiomeric substrate preference of the CTP:phosphoglycerate cytidylyltransferase CpgD
Caulobacter crescentus is a gram-negative bacterium that produces the anionic sphingolipid ceramide diphosphoglycerate that can substitute for the lipopolysaccharide component of the outer membrane. ccna_01210 is a gene in the operon for ceramide diphosphoglycerate synthesis and encodes for the enzyme, CpgD. CpgD is a magnesium-dependent CTP:phosphoglycerate cytidylyltransferase that catalyzes the synthesis of CDP-glycerate, and a pyrophosphate byproduct. CpgD displays substrate specificity for the nucleotide CTP and a preference for 2-phospho-D-glycerate over other phosphoglycerate enantiomers and isomers. Here, we present five high resolution structures for CpgD in various catalytic states that rationalize the specificity and preference of CpgD for its two substrates. This includes structures of apo CpgD, a CpgD-CTP-Mg 2+ ternary complex, and three CpgD-CDP-glycerate-pyrophosphate-Mg 2+ product bound complexes. The structures reveal CpgD nucleotide specificity is mediated by favorable hydrogen bonding interactions with the cytosine nucleobase of CTP, while the preference for 2-phospho-D-glycerate occurs due to favorable van der Waals interactions with the 2D enantiomer and unfavorable steric clashes with the 2L enantiomer. A catalytic mechanism involving a pentacoordinate transition state is proposed based on the observed stereochemical inversion of the α-phosphate in the substrate CTP in comparison to the α-phosphate of the product CDP-glycerate. Overall, this provides insights into the catalytic mechanism, nucleotide specificity, and enantiomeric substrate preference of the cytidylyltransferase CpgD that participates in a unique pathway of bacterial sphingolipid synthesis.
- Open Access
Neutral Sphingomyelinase-2 Restrains TAZ to Suppress Breast Tumor Growth
Loss of tumor suppressor gene (TSG) activity is pervasive across cancers and linked to worse clinical outcomes, yet therapeutic efforts aimed at restoring TSGs have remained elusive. One underexplored avenue to address this problem is the targeting of metabolic signaling pathways that actively enforce tumor suppressive programs. Ceramide (Cer), the central hub of the sphingolipid (SL) metabolic network, has long been thought to have tumor suppressive functions, though its mechanistic roles remain incompletely defined. Here, we identify neutral sphingomyelinase-2 (nSMase2) as a critical mediator of Cer-dependent tumor suppression. We show that nSMase2 is frequently suppressed in breast cancer (BC) and its restoration inhibits tumorigenesis. Biologically, this was linked to the suppression of anchorage-independent growth (AIG) and to restraint of the HIPPO pathway effector TAZ, but not its paralog YAP. Taken together, these findings define a previously unrecognized metabolic tumor suppressor pathway, clarify ambiguities in both SL and HIPPO signaling networks, and highlight reactivation of nSMase2-Cer signaling as a potential therapeutic strategy in BC.
Open AccessNeutral Sphingomyelinase-2 Restrains TAZ to Suppress Breast Tumor Growth
Loss of tumor suppressor gene (TSG) activity is pervasive across cancers and linked to worse clinical outcomes, yet therapeutic efforts aimed at restoring TSGs have remained elusive. One underexplored avenue to address this problem is the targeting of metabolic signaling pathways that actively enforce tumor suppressive programs. Ceramide (Cer), the central hub of the sphingolipid (SL) metabolic network, has long been thought to have tumor suppressive functions, though its mechanistic roles remain incompletely defined. Here, we identify neutral sphingomyelinase-2 (nSMase2) as a critical mediator of Cer-dependent tumor suppression. We show that nSMase2 is frequently suppressed in breast cancer (BC) and its restoration inhibits tumorigenesis. Biologically, this was linked to the suppression of anchorage-independent growth (AIG) and to restraint of the HIPPO pathway effector TAZ, but not its paralog YAP. Taken together, these findings define a previously unrecognized metabolic tumor suppressor pathway, clarify ambiguities in both SL and HIPPO signaling networks, and highlight reactivation of nSMase2-Cer signaling as a potential therapeutic strategy in BC.
- 23 January 2026
- Published by Elsevier
- Vol. 728, 235-251
A fluorescence and HPLC-based activity assay system for lipid-modifying enzymes: Lipin/Pah phosphatidic acid phosphatase as an optimized example
- 23 January 2026
- Published by Elsevier
- Vol. 728, 235-251
A fluorescence and HPLC-based activity assay system for lipid-modifying enzymes: Lipin/Pah phosphatidic acid phosphatase as an optimized example
- Open Access
- 20 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (47)
DDHD2 possesses both lipase and transacylase capacities that remodel triglyceride acyl chains
Hereditary spastic paraplegia subtype SPG54 is a genetic neurological disorder caused by mutations in the DDHD2 gene. Excessive lipid droplet accumulation is observed in the brains of SPG54 patients and DDHD2 knockout mice, consistent with DDHD2’s reported neutral lipase activity. Here, we find recombinant human DDHD2 preferentially hydrolyzes diacylglycerol (DAG) over phospholipids, with a slight preference for DAG over triacylglycerol (TAG). DDHD2 also exhibits transacylase activity, which enables transfer of acyl chains from TAGs to DAGs and monoacylglycerols to remodel the acyl chains of TAGs. A predicted hydrophobic amphipathic helix on DDHD2 is essential for lipid droplet binding in vitro and in cells, and its lack reduces the enzymatic activity and TAG acyl chain remodeling. Adipose triglyceride lipase, but not hormone sensitive lipase, also has transacylation activity and can remodel TAG acyl chains, but to a lesser extent than DDHD2. Taken together, this provides evidence that DDHD2 is a neutral lipid lipase and transacylase whose broad specificity enables TAG acyl-chain remodeling.
- 20 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (47)
Open AccessDDHD2 possesses both lipase and transacylase capacities that remodel triglyceride acyl chains
Hereditary spastic paraplegia subtype SPG54 is a genetic neurological disorder caused by mutations in the DDHD2 gene. Excessive lipid droplet accumulation is observed in the brains of SPG54 patients and DDHD2 knockout mice, consistent with DDHD2’s reported neutral lipase activity. Here, we find recombinant human DDHD2 preferentially hydrolyzes diacylglycerol (DAG) over phospholipids, with a slight preference for DAG over triacylglycerol (TAG). DDHD2 also exhibits transacylase activity, which enables transfer of acyl chains from TAGs to DAGs and monoacylglycerols to remodel the acyl chains of TAGs. A predicted hydrophobic amphipathic helix on DDHD2 is essential for lipid droplet binding in vitro and in cells, and its lack reduces the enzymatic activity and TAG acyl chain remodeling. Adipose triglyceride lipase, but not hormone sensitive lipase, also has transacylation activity and can remodel TAG acyl chains, but to a lesser extent than DDHD2. Taken together, this provides evidence that DDHD2 is a neutral lipid lipase and transacylase whose broad specificity enables TAG acyl-chain remodeling.
- Open Access
- 16 October 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110830
Structures of a lipin/Pah phosphatidic acid phosphatase in distinct catalytic states reveal a signature motif for substrate recognition
- 16 October 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110830
Open AccessStructures of a lipin/Pah phosphatidic acid phosphatase in distinct catalytic states reveal a signature motif for substrate recognition